BranchLab is an AI-native healthcare technology company founded in 2024. It specializes in privacy-first, outcome-based advertising solutions for the healthcare sector, applying deep learning and predictive modeling to its core operations.
The company's flagship product, Pathwai™, is a platform that allows pharmaceutical brands, healthcare marketers, agencies, and media partners to design, activate, and measure advertising audiences. The platform's optimization is focused on real-world health outcomes, such as prescriptions, diagnoses, or healthcare visits.
BranchLab has secured $26 million in Series A funding. Its operational presence spans New York, Colorado, and San Francisco, serving clients across the healthcare, pharmaceutical, government, and retail verticals.
